We first performed a screening with a receptor tyrosine kinase array in four human CRC cell lines (SW620, SW480, LOVO, HCT116) non-responsive to the anti-EGFR targeting drugs, as they harbour mutations in KRAS genes [18-22]. Here, NTRK1 is linked to colorectal carcinoma.